Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis (R21)

The summary for the Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis (R21) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis (R21)
	CFDA Number:	93.394
	CFDA Description:	Cancer Detection and Diagnosis Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Education Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PA-08-267
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Oct 08, 2008
	Creation Date:	Oct 08, 2008
	Original Closing Date for Applications:	Sep 07, 2012
	Current Closing Date for Applications:	Sep 07, 2012
	Archive Date:	Oct 08, 2012
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	$200,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; U.S. Territory or Possession.
Grant Description: -Purpose. This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), invites grant applications from institutions and organizations that are interested in developing and testing innovative methods in cancer detection, diagnosis, and prognosis. The NCI is especially interested in research studies that focus on the development and testing of improved methods for detecting specific characteristics of cancer, which can be subsequently used for the clinical management of cancer patients or individuals who are at risk for (developing) cancer. It is important that research studies focus on the search for molecular and cellular differences between tumors, pre-malignant, or normal tissues. The studies should determine the clinical translational significance of these differences by correlation with clinical parameters, in order to answer clinical problems related to detection, diagnosis, treatment, and prognosis. -Mechanism of Support. This FOA utilizes the NIH Exploratory/Developmental Grant (R21) mechanism. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications; therefore, the anticipated number of awards is not known
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/pa-08-267.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21); • Strategic Partnering to Evaluate Cancer Signatures [SPECS II] (U01); • Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01); • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technolog...; • Opportunity RFA-AI-10-030; • Image-Guided Cancer Interventions (STTR [R41/R42]); • An SBIR Initiative for Image-Guided Cancer Interventions (R43/R44); • IN VIVO CANCER IMAGING EXPLORATORY/DEVELOPMENTAL GRANTS; • Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis; • PHASED APPLICATION AWARDS IN CANCER PROGNOSIS AND PREDICTION